propofol - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PROPOFOL-LIPURO 1% propofol 1000 mg/100 mL emulsion for injection bottle AUST R: 220081Active ingredients:
propofol
Dosage form:
Injection, emulsion
Sponsor:
B Braun Australia Pty Ltd
Phone:
0407660243
|
From
01 Dec 2023
to
23 Dec 2023
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Sponsor is working to expedite the next shipment
|
PROPOFOL-LIPURO 1% propofol 500 mg/50 mL emulsion for injection bottle AUST R: 220083Active ingredients:
propofol
Dosage form:
Injection, emulsion
Sponsor:
B Braun Australia Pty Ltd
Phone:
0407660243
|
From
01 Dec 2023
to
23 Dec 2023
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Management action:
Sponsor is working to expedite the next shipment.
|
FRESOFOL 1% MCT/LCT propofol 500mg/50mL emulsion for intravenous injection/infusion vial AUST R: 193609Active ingredients:
propofol
Dosage form:
Injection, emulsion
Sponsor:
Fresenius Kabi Australia Pty Ltd
Phone:
0293915555
|
From
28 Mar 2024
to
17 Apr 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
|
PROVIVE MCT-LCT 1% propofol 1000mg/100mL emulsion for injection vial AUST R: 162320Active ingredients:
propofol
Dosage form:
Injection, emulsion
Sponsor:
Baxter Healthcare Pty Ltd
Phone:
1300302409
|
Deletion from market:
31 May 2024
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products available.
|